Hubei Jiuzhoutong Health Industry Co., Ltd. announced that it expects to receive CNY 900 million in funding from Jointown Pharmaceutical Group Co., Ltd.
January 12, 2018
Share
Hubei Jiuzhoutong Health Industry Co., Ltd. announced that it will receive CNY 900 million in an equity round of funding from existing investor Jointown Pharmaceutical Group Co., Ltd. (SHSE:600998) on January 13, 2018. Post the closing of the transaction, the investor will continue to hold 100% stake in the company. The registered capital of the company will increase from CNY 100,000,000 to CNY 1,000,000,000 upon completion of the transaction. The transaction was approved by the board of directors in 4th meeting of the 4th directorate.
Jointown Pharmaceutical Group Co., Ltd. is principally engaged in the wholesaling and retailing of pharmaceuticals and medical equipments. The Company is also engaged in the research, development and production of drugs, as well as the provision of relevant value-added services. The Companyâs products mainly include western medicines, proprietary Chinese medicines, Chinese medicine pieces, Chinese herbal medicines, medical equipments, health care products, cosmetics, among others. The Company mainly provides services to direct sales or franchise stores through its retailing businesses.
Hubei Jiuzhoutong Health Industry Co., Ltd. announced that it expects to receive CNY 900 million in funding from Jointown Pharmaceutical Group Co., Ltd.
JOINTOWN PHARMACEUTICAL GROUP CO., LTD 
